NCT03894579View on ClinicalTrials.gov

Autologous Natural Killer Cells in Subjects With Plaque Psoriasis

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 18, 2019

Primary Completion Date

December 3, 2019

Study Completion Date

December 3, 2019

Conditions
Plaque Psoriasis
Interventions
BIOLOGICAL

Study Product: SNK01

SNK01 administered using an intravenous line (IV) to all patients at weeks 1, 2, 3, and 4

Trial Locations (1)

22010

Hospital Angeles, Tijuana

Sponsors
All Listed Sponsors
lead

NKGen Biotech, Inc.

INDUSTRY

NCT03894579 - Autologous Natural Killer Cells in Subjects With Plaque Psoriasis | Biotech Hunter | Biotech Hunter